Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Mr. Chad Robins$377.2M
Market Cap • 24/04/20242009
(há 15 anos)
2019
(5 years ago)
NASDAQ
Listagem
Seattle
Sede • Washington790
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
ADPTSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.